Is Buying Penumbra Inc (NYSE:PEN) Here Good Idea?

June 5, 2018 - By Marie Mckinney

Penumbra, Inc. (NYSE:PEN) Logo

The stock of Penumbra Inc (NYSE:PEN) registered a decrease of 4.51% in short interest. PEN’s total short interest was 2.06M shares in June as published by FINRA. Its down 4.51% from 2.16 million shares, reported previously. With 162,400 shares average volume, it will take short sellers 13 days to cover their PEN’s short positions. The short interest to Penumbra Inc’s float is 6.77%.

The stock decreased 0.51% or $0.85 during the last trading session, reaching $164.25. About 40,554 shares traded. Penumbra, Inc. (NYSE:PEN) has risen 85.64% since June 5, 2017 and is uptrending. It has outperformed by 73.07% the S&P500.

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company has market cap of $5.63 billion. The firm offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PX SLIM, and Velocity brands; aspiration based thrombectomy systems and accessory devices under the Penumbra System brand; and revascularization device for mechanical thrombectomy under the 3D brand. It has a 1263.46 P/E ratio. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands; and neurovascular stents for stent-assisted coiling in large and wide-neck aneurysms under the LIBERTY Stent brand.

More recent Penumbra, Inc. (NYSE:PEN) news were published by: Benzinga.com which released: “10 Biggest Price Target Changes For Thursday” on May 31, 2018. Also Benzinga.com published the news titled: “Benzinga’s Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO” on June 01, 2018. Seekingalpha.com‘s news article titled: “Penumbra’s (PEN) CEO Adam Elsesser on Q1 2018 Results – Earnings Call Transcript” with publication date: May 12, 2018 was also an interesting one.

Penumbra, Inc. (NYSE:PEN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: